Table 1.
Characteristics of patients (n = 77).
| Characteristic | Value* |
|---|---|
| Age at time of procedure, median (IQR) (months) | 6 (4–12) |
| Weight at time of procedure, median (IQR) (kg) | 5.7 (3.7–8.4) |
| Sex | |
| Male | 42 (54.5) |
| Female | 35 (45.5) |
| ASA classification | |
| 2 | 4 (2.9) |
| 3 | 73 (53.3) |
| 4 | 58 (42.3) |
| 5 | 2 (1.5) |
| Severity of PH at time of procedure | |
| Controlled on pharmacologic therapy | 18 (12.2) |
| Mild | 82 (55.4) |
| Moderate | 28 (18.9) |
| Severe | 20 (13.5) |
| PH classification per Pulmonary Vascular Institute Consensus approach12 | |
| Group 1 (prenatal/developmental pulmonary hypertensive vascular disease) | 14 (18.2) |
| Group 2 (perinatal pulmonary vascular maladaptation) | 3 (3.9) |
| Group 3 (pediatric cardiovascular disease) | 22 (28.6) |
| Group 4 (bronchopulmonary dysplasia) | 36 (46.8) |
| Group 5 (isolated pulmonary arterial hypertension) | 1 (1.3) |
| Group 10 (associated with other system disorders) | 1 (1.3) |
*
All data are presented as n (%) except where noted.
ASA, American Society of Anesthesiologists Physical Status; IQR, interquartile range; PH, pulmonary hypertension.